Stock Updates

Today’s Top Gainers in the Market Bristol-Myers Squibb Company (NYSE:BMY) from Healthcare

Today’s top gainers include the company Bristol-Myers Squibb Company (NYSE:BMY) which is in the industry Drug Manufacturers – Major, gaining 0.25% today. In the last week its performance is 3.63%, and 13.71% for the past quarter. Currently, Bristol-Myers Squibb Company, BMY has a target price of 76.48, so today’s gain of 0.25% is a significant step towards its target price. The GAP today is therefore 0.27%.

Bristol-Myers Squibb Company (NYSE:BMY), has a market cap of 128129.12, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 74.40%.

At the current price of 76.77, it has a dividend yield of 1.98%, and its target price is 76.48. This is with a profit margin of 9.30%, and total debt/equity of 0.47. Bristol-Myers Squibb Company (NYSE:BMY) has a P/E of 82.02, as well as a forward P/E of 23.86.

With a current EPS of 0.94, and a forecasted EPS growth for next year at 25.80%,Bristol-Myers Squibb Company (NYSE:BMY) has had a EPS growth for the past five years at -12.20%. For the next five years EPS growth is projected to be 22.85%.

Performance for the year is 13.39%. Since its IPO date on 6/1/1972, the total performance to date is 12.86%.

Volume today for Bristol-Myers Squibb Company (NYSE:BMY), is 4350375, while its average volume is 5955.38. Whilst the total gain today was 0.25%, it did have a day high of -0.16%.

Volatility for this week has been at 1.34%, and 1.60% for the month. The 52-week low for Bristol-Myers Squibb Company, BMY has been 51.59%, while the 52-week-high has reached -0.16%.

Looking at its return of investments, which is 4.60%, and its return on assets is 4.90%. Bristol-Myers Squibb Company (NYSE:BMY) has an operating margin of 11.60%. With a sales growth of 8.70% quarter over quarter. Bearing in mind that Bristol-Myers Squibb Company, BMY is in the sector Healthcare, its long-term debt/equity is 0.46, and has a current ratio of 1.5 and 1.3 for quick ratio.

So what is the value of Bristol-Myers Squibb Company? Well its PEG is 3.59, and the P/S is 7.58, along with a P/B of 8.91. Meanwhile it has a p/cash of 29.75.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment